Short- and Long-term Central Action of Botulinum Neurotoxin Treatment in Laryngeal Dystonia

BACKGROUND AND OBJECTIVES: Laryngeal dystonia (LD) is isolated task-specific focal dystonia selectively impairing speech production. The first choice of LD treatment is botulinum neurotoxin (BoNT) injections into the affected laryngeal muscles. However, whether BoNT has a lasting therapeutic effect...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Flynn, Lena C., Simonyan, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536744/
https://www.ncbi.nlm.nih.gov/pubmed/35764404
http://dx.doi.org/10.1212/WNL.0000000000200850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536744/
https://www.ncbi.nlm.nih.gov/pubmed/35764404
http://dx.doi.org/10.1212/WNL.0000000000200850

Ejemplares similares